Adempas and Radial nerve dysfunction - a phase IV clinical study of FDA data


Radial nerve dysfunction is reported only by a few people who take Adempas.

The phase IV clinical study analyzes which people take Adempas and have Radial nerve dysfunction. It is created by eHealthMe based on reports of 24,196 people who have side effects while taking Adempas from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 28, 2023

24,196 people reported to have side effects when taking Adempas.
Among them, 1 person (0.0%) has Radial nerve dysfunction.

What is Adempas?

Adempas has active ingredients of riociguat. eHealthMe is studying from 24,210 Adempas users for its effectiveness, alternative drugs and more.

What is Radial nerve dysfunction?

Radial nerve dysfunction (damage to arm nerve) is found to be associated with 546 drugs and 379 conditions by eHealthMe.

Number of Adempas and Radial nerve dysfunction reports submitted per year:

Could Adempas cause Radial nerve dysfunction?

Gender of people who have Radial nerve dysfunction when taking Adempas *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Radial nerve dysfunction when taking Adempas *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Adempas *:

  1. Vitamin D3: 1 person, 100.00%
  2. Tylenol: 1 person, 100.00%
  3. Pantoprazole: 1 person, 100.00%
  4. Opsumit: 1 person, 100.00%
  5. Ondansetron: 1 person, 100.00%
  6. Iopamidol: 1 person, 100.00%
  7. Deltasone: 1 person, 100.00%
  8. Creon: 1 person, 100.00%
  9. Celexa: 1 person, 100.00%

Common side effects people have besides Radial nerve dysfunction *:

  1. White Blood Cell Count Decreased: 1 person, 100.00%
  2. Fatigue (feeling of tiredness): 1 person, 100.00%
  3. Dyspnea Exertional: 1 person, 100.00%
  4. Electrocardiogram Qt Prolonged: 1 person, 100.00%
  5. Electrocardiogram T Wave Inversion: 1 person, 100.00%
  6. Enlarged Heart: 1 person, 100.00%
  7. Fainting (loss of consciousness and postural tone): 1 person, 100.00%
  8. Fall: 1 person, 100.00%
  9. Fever: 1 person, 100.00%
  10. Depression: 1 person, 100.00%

Common conditions people have *:

  1. Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 1 person, 100.00%
  2. Stress And Anxiety: 1 person, 100.00%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 100.00%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 100.00%
  5. Pain: 1 person, 100.00%
  6. Nausea (feeling of having an urge to vomit): 1 person, 100.00%
  7. Fever: 1 person, 100.00%
  8. Diarrhea: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Adempas and have Radial nerve dysfunction?

Check whether Radial nerve dysfunction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Radial nerve dysfunction and when was it recovered:

Expand to all the drugs that have ingredients of riociguat:

Alternative drugs to, pros and cons of Adempas:

Common Adempas side effects:

Browse all side effects of Adempas:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Radial nerve dysfunction treatments and more:

COVID vaccines that are related to Radial nerve dysfunction:

All the drugs that are associated with Radial nerve dysfunction:

All the conditions that are associated with Radial nerve dysfunction:

How the study uses the data?

The study uses data from the FDA. It is based on riociguat (the active ingredients of Adempas) and Adempas (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: